Literature DB >> 15950248

Endocannabinoids restrict hippocampal long-term potentiation via CB1.

Kristen A Slanina1, Marisa Roberto, Paul Schweitzer.   

Abstract

Cannabinoid ligands alter cognition and prevent long-term potentiation (LTP) of synaptic transmission, but the influence of endogenously formed cannabinoids (eCBs) on hippocampal LTP remains ambiguous. In the accompanying study, we showed that eCB levels regulated by cyclooxygenase-2 (COX-2) tonically decrease basal excitatory transmission. Here, we investigated the influence of eCBs on LTP in CA1 hippocampus. LTP elicited by moderate stimulations (20 or 50 pulses) was facilitated in slices treated with a CB1 antagonist, whereas LTP elicited with robust stimulations (100 or 200 pulses) was unchanged by CB1 blockade. LTP elicited with theta-burst stimulations also was facilitated with CB1 blockade, revealing a tonic inhibitory influence of eCBs on LTP induction. Conversely, inhibition of COX-2 prevented LTP elicited with theta burst stimulations. Inhibition of COX-1 or other routes of eCB degradation did not affect LTP. We conclude that COX-2 regulates the formation of CB1 ligands that negatively regulate LTP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950248     DOI: 10.1016/j.neuropharm.2005.04.021

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  31 in total

1.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

2.  A biophysically-based neuromorphic model of spike rate- and timing-dependent plasticity.

Authors:  Guy Rachmuth; Harel Z Shouval; Mark F Bear; Chi-Sang Poon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-16       Impact factor: 11.205

3.  Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.

Authors:  Önder Albayram; Stefan Passlick; Andras Bilkei-Gorzo; Andreas Zimmer; Christian Steinhäuser
Journal:  Pflugers Arch       Date:  2016-01-07       Impact factor: 3.657

4.  Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.

Authors:  Alexander F Hoffman; Murat Oz; Ruiqin Yang; Aron H Lichtman; Carl R Lupica
Journal:  Learn Mem       Date:  2007-01-03       Impact factor: 2.460

Review 5.  Cyclooxygenase-2 in synaptic signaling.

Authors:  Hongwei Yang; Chu Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor.

Authors:  Hongwei Yang; Jian Zhang; Richard M Breyer; Chu Chen
Journal:  J Neurochem       Date:  2008-11-21       Impact factor: 5.372

7.  CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-02       Impact factor: 3.899

8.  Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.

Authors:  Balapal S Basavarajappa; Ipe Ninan; Ottavio Arancio
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

Review 9.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

10.  Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.

Authors:  Zsuzsanna Sidló; Patricia H Reggio; Margaret E Rice
Journal:  Neurochem Int       Date:  2007-07-22       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.